Aggressive extensive cardiac mass in an HIV-1-infected patient: should we go for comfort therapy?

Delphine Mtf Vervloet1, Michel De Pauw1, Laurent Demulier1

  • 1a Cardiology Department , University Hospital Ghent , Ghent , Belgium.

Acta Clinica Belgica
|June 30, 2016
PubMed

Insights

A rare giant cardiac mass in an HIV-1 patient was diagnosed as Burkitt lymphoma. Aggressive chemotherapy led to complete remission, demonstrating treatment efficacy even in advanced cases.

Area of Science:

  • Cardiology
  • Oncology
  • Infectious Diseases

Background:

  • Cardiac masses are uncommon, with diverse etiologies including infections, neoplasms, and thrombi.
  • Accurate diagnosis and therapeutic planning for cardiac masses necessitate pathology specimens, even with advanced imaging.
  • HIV-1 infection can present with complex cardiac manifestations.

Observation:

  • A 49-year-old male with HIV-1 presented with progressive edema, atrial fibrillation, and a giant cardiac mass involving both atria and surrounding tissues.
  • The cardiac mass was deemed inoperable due to its extensive and invasive nature.
  • Positron Emission Tomography-Computed Tomography (PET-CT) scan was used for staging.

Findings:

  • The patient was diagnosed with stage IV Burkitt lymphoma with significant extranodal cardiac involvement.
  • Initial treatment followed the GMALL B-NHL86 protocol, later modified to R-CHOP due to tolerance issues.
  • The patient achieved complete remission with no evidence of relapse during follow-up.

Implications:

  • This case highlights the importance of considering lymphoma in the differential diagnosis of cardiac masses, particularly in immunocompromised patients.
  • Aggressive chemotherapy, even when modified, can be effective in treating advanced cardiac Burkitt lymphoma.
  • Prompt diagnosis and tailored therapy are crucial for improving outcomes in rare cardiac malignancies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
442
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732